Clinical Trial Update: A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adults [Phase 1]

View source ↗

Summary

This document describes a Phase 1 clinical trial to assess the safety and immunogenicity of the IN006 respiratory syncytial virus vaccine in healthy adults; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• IN006

Snippet

Sponsor: Shenzhen Shenxin Biotechnology Co., Ltd | Conditions: Respiratory Syncytial Virus Infections | Phase 1 | Status: NOT_YET_RECRUITING